Unlock stock picks and a broker-level newsfeed that powers Wall Street.

AbbVie Raises Full-Year Outlook as First-Quarter Results Top Street Estimates

In This Article:

AbbVie (ABBV) lifted its full-year outlook on Friday as the biopharmaceutical company recorded first

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.